Neurofibromatosis type 1: results of our own study (Republic of Bashkortostan)

Introduction. Neurofibromatosis type 1 (NF1) is the most common hereditary tumor syndrome (frequency of its occurrence in the world is 1 : 3000 of the population). The main clinical manifestations of the disease are multiple café-au-lait macules on the skin and neurofibromas, skeletal abnormalities...

Full description

Bibliographic Details
Main Authors: R. N. Mustafin, M. A. Bermisheva, R. R. Valiev, E. E. Khusnutdinova
Format: Article
Language:Russian
Published: ABV-press 2021-05-01
Series:Успехи молекулярной онкологии
Subjects:
Online Access:https://umo.abvpress.ru/jour/article/view/328
_version_ 1797702272782696448
author R. N. Mustafin
M. A. Bermisheva
R. R. Valiev
E. E. Khusnutdinova
author_facet R. N. Mustafin
M. A. Bermisheva
R. R. Valiev
E. E. Khusnutdinova
author_sort R. N. Mustafin
collection DOAJ
description Introduction. Neurofibromatosis type 1 (NF1) is the most common hereditary tumor syndrome (frequency of its occurrence in the world is 1 : 3000 of the population). The main clinical manifestations of the disease are multiple café-au-lait macules on the skin and neurofibromas, skeletal abnormalities and cognitive deficits. The disease is based on mutations in the oncosuppressor gene NF1. This disease is characterized by significant clinical polymorphism of manifestations, even among members of the same family. No geno-phenotypic correlations were found for NF1. Therefore, it is assumed that modifier genes are the cause of the varying expressiveness of the disease. Materials and methods. Clinical-epidemiological and molecular-genetic research of patients with NF1 in the Republic of Bashkortostan (RB) was carried out. Sequencing was used to search for intragenic mutations in 57 exons of the NF1 gene. Microsatellite analysis was used to detect the deletion of the entire gene.Results. The frequency of occurrence of NF1 in RB was 1 : 10153 of the population. Analysis of the clinical manifestations of NF1 in RB patients showed a lower incidence of brain cysts in patients born in mixed marriages, which indicates the protective role of mestization. In patients with NF1 who inherited the disease from the mother, a more frequent development of skeletal anomalies and facial dysmorphism was determined. We identified 1 deletion of the entire NF1 gene in 1 patient and 14 intragenic mutations (c.205-1G>C, с.1278G>A, c.1369_1370insGGGTC, с.1570G>A, с.1973_1974delTC, c.2806A>T, с.2991-1G>C, c.3158C>G, с.3526_3528delAGA, с.3826delC, с.4514+5G>A, с.4537С>Т, c.5758_5761delTTGA, с.6792С>A) in 20 patients with NF1. We determined the random distribution of the types of mutations and did not reveal the specific features of the NF1 clinic depending on the type of mutations.Conclusions. The protective role of crossbreeding in relation to brain cysts, as well as the predominance of skeletal anomalies in patients with NF1 inheritance from the mother, indicate the role of modifier genes in the pathogenesis of the disease. The identified mutations in the NF1 gene will allow us to perform prenatal prevention of NF1 in RB patients.
first_indexed 2024-03-12T04:48:36Z
format Article
id doaj.art-1d96070a431d4d62869db3d133f6d80c
institution Directory Open Access Journal
issn 2313-805X
2413-3787
language Russian
last_indexed 2024-03-12T04:48:36Z
publishDate 2021-05-01
publisher ABV-press
record_format Article
series Успехи молекулярной онкологии
spelling doaj.art-1d96070a431d4d62869db3d133f6d80c2023-09-03T09:26:36ZrusABV-pressУспехи молекулярной онкологии2313-805X2413-37872021-05-0181172510.17650/2313-805X-2021-8-1-17-25201Neurofibromatosis type 1: results of our own study (Republic of Bashkortostan)R. N. Mustafin0M. A. Bermisheva1R. R. Valiev2E. E. Khusnutdinova3ФГБОУ ВО «Башкирский государственный медицинский университет»Институт биохимии и генетики ФГБНУ «Уфимский федеральный исследовательский центр» РАНФГБОУ ВО «Башкирский государственный университет»Институт биохимии и генетики ФГБНУ «Уфимский федеральный исследовательский центр» РАНIntroduction. Neurofibromatosis type 1 (NF1) is the most common hereditary tumor syndrome (frequency of its occurrence in the world is 1 : 3000 of the population). The main clinical manifestations of the disease are multiple café-au-lait macules on the skin and neurofibromas, skeletal abnormalities and cognitive deficits. The disease is based on mutations in the oncosuppressor gene NF1. This disease is characterized by significant clinical polymorphism of manifestations, even among members of the same family. No geno-phenotypic correlations were found for NF1. Therefore, it is assumed that modifier genes are the cause of the varying expressiveness of the disease. Materials and methods. Clinical-epidemiological and molecular-genetic research of patients with NF1 in the Republic of Bashkortostan (RB) was carried out. Sequencing was used to search for intragenic mutations in 57 exons of the NF1 gene. Microsatellite analysis was used to detect the deletion of the entire gene.Results. The frequency of occurrence of NF1 in RB was 1 : 10153 of the population. Analysis of the clinical manifestations of NF1 in RB patients showed a lower incidence of brain cysts in patients born in mixed marriages, which indicates the protective role of mestization. In patients with NF1 who inherited the disease from the mother, a more frequent development of skeletal anomalies and facial dysmorphism was determined. We identified 1 deletion of the entire NF1 gene in 1 patient and 14 intragenic mutations (c.205-1G>C, с.1278G>A, c.1369_1370insGGGTC, с.1570G>A, с.1973_1974delTC, c.2806A>T, с.2991-1G>C, c.3158C>G, с.3526_3528delAGA, с.3826delC, с.4514+5G>A, с.4537С>Т, c.5758_5761delTTGA, с.6792С>A) in 20 patients with NF1. We determined the random distribution of the types of mutations and did not reveal the specific features of the NF1 clinic depending on the type of mutations.Conclusions. The protective role of crossbreeding in relation to brain cysts, as well as the predominance of skeletal anomalies in patients with NF1 inheritance from the mother, indicate the role of modifier genes in the pathogenesis of the disease. The identified mutations in the NF1 gene will allow us to perform prenatal prevention of NF1 in RB patients.https://umo.abvpress.ru/jour/article/view/328ген nf1гено-фенотипические корреляцииканцерогенезмутациинейрофиброминнейрофиброматоз 1-го типа
spellingShingle R. N. Mustafin
M. A. Bermisheva
R. R. Valiev
E. E. Khusnutdinova
Neurofibromatosis type 1: results of our own study (Republic of Bashkortostan)
Успехи молекулярной онкологии
ген nf1
гено-фенотипические корреляции
канцерогенез
мутации
нейрофибромин
нейрофиброматоз 1-го типа
title Neurofibromatosis type 1: results of our own study (Republic of Bashkortostan)
title_full Neurofibromatosis type 1: results of our own study (Republic of Bashkortostan)
title_fullStr Neurofibromatosis type 1: results of our own study (Republic of Bashkortostan)
title_full_unstemmed Neurofibromatosis type 1: results of our own study (Republic of Bashkortostan)
title_short Neurofibromatosis type 1: results of our own study (Republic of Bashkortostan)
title_sort neurofibromatosis type 1 results of our own study republic of bashkortostan
topic ген nf1
гено-фенотипические корреляции
канцерогенез
мутации
нейрофибромин
нейрофиброматоз 1-го типа
url https://umo.abvpress.ru/jour/article/view/328
work_keys_str_mv AT rnmustafin neurofibromatosistype1resultsofourownstudyrepublicofbashkortostan
AT mabermisheva neurofibromatosistype1resultsofourownstudyrepublicofbashkortostan
AT rrvaliev neurofibromatosistype1resultsofourownstudyrepublicofbashkortostan
AT eekhusnutdinova neurofibromatosistype1resultsofourownstudyrepublicofbashkortostan